Comparative pharmacodynamic studies with the novel serotonin uptake-enhancing tianeptine and - Inhibiting fluvoxamine utilizing EEG mapping and psychometry

Journal of Neural Transmission

Volumn 103, Issue 1-2, 1996, Pages 191-216

  Saletu, B ^a   Grunberger J ^a   Anderer, P ^a   Linzmayer, L ^a   Zyhlarz, G ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; FLUVOXAMINE; SEROTONIN; TIANEPTINE;

ADULT; ALPHA RHYTHM; ARTICLE; BETA RHYTHM; BLOOD PRESSURE; BLOOD SAMPLING; BRAIN FUNCTION; CENTRAL NERVOUS SYSTEM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DELTA RHYTHM; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG EFFECT; ELECTROENCEPHALOGRAM; FATIGUE; FEMALE; HEADACHE; HUMAN; HUMAN EXPERIMENT; LEFT HEMISPHERE; MALE; MOOD; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PARESTHESIA; PHARMACODYNAMICS; POWER SPECTRUM; PRIORITY JOURNAL; PSYCHOMETRY; PSYCHOPHYSIOLOGY; PULSE RATE; PUPIL REFLEX; RANDOMIZED CONTROLLED TRIAL; SEDATION; SEROTONIN UPTAKE; SKIN CONDUCTANCE; THETA RHYTHM; VERTIGO; XEROSTOMIA;

ADULT; ANALYSIS OF VARIANCE; ANTIDEPRESSIVE AGENTS, TRICYCLIC; BRAIN MAPPING; DOUBLE-BLIND METHOD; ELECTROENCEPHALOGRAPHY; FEMALE; FLUVOXAMINE; HUMANS; MALE; PSYCHOMETRICS; SEROTONIN UPTAKE INHIBITORS; THIAZEPINES;

EID: 0030058288     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01292627     Document Type: Article

References (82)

1. Anderer P, Saletu B, Kinsperger K, Semlitsch H (1987) Topographie brain mapping of EEG in neuropsychopharmacology, part I. Methodological aspects. Meth Find Exp Clin Pharmacol 9(6): 371-384
2. Anderer P, Semlitsch HV, Saletu B, Barbanoj MJ (1992) Artifact processing in topographic mapping of electroencephalographic activity in neuropsychopharmacology. Psychiatry Res 45: 79-93
3. Angst J, Bech P, Boyer P, Bruinvels J, Engel R, Helmchen H, Hippius H, Lingjaerde O, Racagni G, Saletu B, Sedvall G, Silverstone JT, Stefanis CN, Stoll K, Woggon B (1989) Consensus conference on the methodology of clinical trials of antidepressants,
4. Zurich, March 1988: report of the consensus committee. Pharmacopsychiat 22: 3-7
5. Antonijoan RM, Barbanoj MJ, Anderer P, Torrent J, Jane F, Saletu B (1994) Antidepressants and anxiolytics: their interaction on vigilance. J Psychophysiol 8: 248
6. Bartels PH, Subach JA (1976) Automated interpretation of complex scenes. In: Preston E, Onoe M (eds) Digital processing of biomédical imagery. Academic Press, New York, pp 101-114
7. Blier P, Mongeau R, Weiss M, de Montigny C (1993) Modulation of serotonin neurotransmission by presynaptic alpha-2-adrenergic receptors: a target for antidepressant pharmacotherapy? In: Mendlewicz J, Brunello N, Langer SZ, Racagni G (eds) New pharmacological approaches to the therapy of depressive disorders. International Academy for Biomédical Drug Research, vol 5. Karger, Basel, pp 74-82
8. Bruder GE, Yozawita A (1979) Central auditory processing and laterality in psychiatric patients. In: Gruzelier J, Flor-Henry P (eds) Hemisphere asymmetries of function and psychopathology. Elsevier, Amsterdam
9. Brumback RA, Staton RD, Wilson H (1980) Neuropsychological study of children during and after remission of endogenous depressive episodes. Percept Mot Skills 50: 1163-1167
10. Brunello N, Riva M, Volterra A, Racagni G (1987) Effect of some tricylic and nontricyclic antidepressants on [3]imipramine binding and serotonin uptake in rat cerebral cortex after prolonged treatment. Fundam Clin Pharmacol 1: 327-333
11. Casacchia M, Sconci V, Vespucci G, Brancato T (1989) Double blind clinical study of tianeptine, a new 5-HT uptake enhancer. International Symposium on Serotonin: From Cell Biology to Pharmacology and Therapeutics, Florence, p 92
12. Chamba G, Lemoine P, Flachaire E, Ferry N, Quincy C, Sassard J, Ferber C, Mocaer E, Kamoun A, Renaud B (1991) Increased serotonin platelet uptake after tianeptine administration in depressed patients. Biol Psychiatry 30: 609-617
13. Costa e Suva JA, Ruschel S (1994) Tianeptine versus placebo study in major depressions and depressive bipolar disorders. Eur Psychiatry 9 [Suppl 1]: 140
14. Davidson RJ (1987) EEG measures of cerebral asymmetry: conceptual and methodological issues. Int J Neurosci 39: 69-71
15. Defrance R, Marey C, Kamoun A (1988) Antidepressant and anxiolytic activities of tianeptine. An overview of clinical trials. Clin Neuropharmacol 11 [Suppl 2]: 74-82
16. Delagrange P, Bouyer JJ, Durand C, Mocaer E, Rougeul A (1990) Action of tianeptine on focalization of attention in cat. Psychopharmacology 102: 227-233
17. Delbende C, Contesse V, Mocaer E, Kamoun A, Vaudry H (1991) The novel antidepressant, tianeptine, reduces stress-evoked stimulation of the hypothalamo-pituitaryadrenal axis. Eur J Pharmacol 202: 391-396
18. De Montigny C, Chaput Y, Blier P (1993) Classical and novel targets for antidepressant drugs. In: Mendlewicz J, Brunello N, Langer SZ, Racagni G (eds) New pharmacological approaches to the therapy of depressive disorders. International Academy for Biomédical Drug Research, vol 5. Karger, Basel, pp 8-17
19. De Simoni MG, De Luigi A, Manfridi A, Sokola A (1989) Tianeptine enhancement of serotonin uptake: an in vivo voltametric study. International Symposium on Serotonin From Cell Biology to Pharmacology and Therapeutics, Florence, March 29-April 1, 1989, p 87 (Abstract)
20. Duffy FH, Bartels PH, Burchfield JL (1981) Significance probability mapping: an aid in the topographic analysis of brain electrical activity. Electroencephalogr Clin Neurophysiol 51: 455-462
21. El Mestikawy S, Gozlan H, Ménard F, Bourgoin S, Hamon M (1988) Interactions of the potential antidepressant tianeptine with central serotonin receptors in the rat brain. Fifth International Meeting on Clinical Pharmacology and Psychiatry, Tromso, p 31
22. Fattacini CM, Bolanos-Jimenez F, Gozlan H, Hamon M (1990) Tianeptine stimulates uptake of 5-hydroxytryptamine in vivo in the rat brain. Neuropharmacology 29: 1-8
23. File SE, Mabbutt PS (1991) Effects of tianeptine in animal models of anxiety and on learning and memory. Drug Dev Res 23: 47-56
24. Flor-Henry P (1974) Psychosis, neurosis and epilepsy: developmental and gender-related effects and their aetiological contribution. Br J Psychiatry 124: 144-150
25. Flor-Henry P (1976) Lateralized temporal-limibic dysfunction and psychopathology. Ann NY Acad Sei 280: 777-797
26. Gasser T, Bächer P, Möcks J (1982) Transformation towards the normal distribution of broad band spectrum parameters of the EEG. Clin Neurophysiol 43: 119-124
27. Grahame-Smith DG (1992) Serotonin in affective disorders. In: Montgomery SA (ed) Selective serotonin reuptake inhibitors in psychiatric practice. Rapid Communications of Oxford Ltd, Oxford, pp 5-13
28. Grislain L, Gelé P, Bertrand M, Luijten W, Bromet N, Salvadori C, Kamoun A (1990) The metabolic pathways of tianeptine, a new antidepressant, in healthy volunteers. Drug Metab Dis 18(5): 804-808
29. Griinberger J (1977) Psychodiagnostik des Alkoholkranken. Ein methodischer Beitrag zur Bestimmung der Organizität in der Psychiatrie. Maudrich, Wien
30. Grünberger J, Linzmayer L, Saletu B (1984) Klinische Psychodiagnostik mit Hilfe psychophysiologischer Verfahren. Wien Med Wochenschr 134: 29-35
31. Guelfi JD (1992) Efficacy of tianeptine in comparative trials versus reference antidepressants: an overview. Br J Psychiatry 160 [Suppl 15]: 72-75
32. Hamon M, Bourgoin S, Gozlan H (1989) Effet de la tianeptine sur la libération de la [3H]5 HT et sur les divers types de récepteurs sérotoninergiques dans le système nerveux chez le rat. J Psychiatr Biol Ther (March): 32-35
33. Herrmann WM (1982) Development and critical evaluation of an objective procedure for the electroencephalographic classification of psychotropic drugs. In: Herrmann WM (ed) Electroencephalography in drug research. Fischer, Stuttgart New York, pp 249-351
34. Herrmann WM, Schärer E (1986) Das Pharmako-EEG und seine Bedeutung für die klinische Pharmakologie. In: Kuemmerle HP, Hitzenberger G, Spitzy KH (eds) Klinische Pharmakologie, 4th edn. Landsberg, München, pp 1-71
35. Invernizzi R, Pozzi L, Garattini S, Samanin R (1992) Tianeptine increases the extracellular concentrations of dopamine in the nucleus accumbens by a serotonin-independent mechanism. Neuropharmacology 31: 221-227
36. Itil TM (1982) The significance of quantitative pharmaco-EEG in the discovery and classification of psychotropic drugs. In: Herrmann WM (ed) Electroencephalography in drug research. Fischer, Stuttgart New York, pp 131-157
37. Itil TM, Shapiro DM, Eralp E, Akmann A, Itil KZ, Garbizu C (1985) A new brain function diagnostic unit, including the dynamic brain mapping of computer analyzed EEG, evoked potentials and sleep (a new hardware/software system and its application in psychiatry and psychopharmacology). New Trends Exp Clin Psychiatry 1: 107-177
38. Jaffard R, Mocaer E, Poignant JC, Micheau J, Marighetto A, Meunier M, Beracochea D (1991) Effects of tianeptine on spontaneous alternation, simple and concurrent spatial discrimination learning and on a sequential alternation deficit induced by longterm ethanol administration in mice. Behav Pharmacol 2: 37-46
39. Kato G, Weitsch AF (1988) Neurochemical profile of tianeptine a new antidepressant drug. Clin Neuropharmacol 11 [Suppl 2]: 43-50
40. Kelly JP, Leonard BE (1990) The effect of tianeptine on the olfactory bulbectomized (OB) rat model of depression. Third Int Congress of Europ Behavioural Pharmacology Meeting, Noordwigkhout, The Netherlands, June 25-27, 1990
41. Kronfol Z, Hamsher K, Digre K, Waziri R (1978) Depression and hemispheric functions: changes associated with unilateral ECT. Br J Psychiatry 132: 560-567
42. Labrid C, Moleyre J, Poignant JC, Malen C, Mocaer E, Kamoun A (1988) Structureactivity relationship of tricyclic antidepressants, with special reference to tianeptine. Clin Neuropharmacol 11 [Suppl 2]: 21-31
43. Lejeune F, Poignant JC, Reure H (1988) Etude électrophysiologique de la tianeptine, nouveau stimulant du recaptage de la sérotonine possédant une activité antidépressive. Neurophysiol Clin 18: 369-381
44. Loo H, Deniker P (1988) Position of tianeptine among antidepressive chemotherapies. Clin Neuropharmacol 11 [Suppl 2]: 97-102
45. Matousek M, Capone C, Okawa M (1981) Measurement of the interhemispheral differences as a diagnostic tool in psychiatry. Adv Biol Psychiat 6: 76-80
46. Mennini T, Mocaer E, Garattini S (1987) Tianeptine, a selective enhancer of serotonin uptake in rat brain. Naunyn Schmiedebergs Arch Pharmacol 336: 478-482
47. Mocaer E, Rettori MC, Kamoun A (1988a) Pharmacological antidepressive effects and tianeptine-induced 5-HT uptake increase. Clin Neuropharmacol 11 [Suppl 2]: 32-42
48. Mocaer E, Lagarde D, Balzamo E, Milhaud C (1988b) Effects of tianeptine on sleepwakefulness cycles and EEG in monkey. Abstracts of the XVIth C.I.N.P. Congress, Munich August 15-19, 1988. Psychopharmacology 96 [Suppl]: 275
49. Nicot G, Lachatre G, Gönnet C, Mallon J, Mocaer E (1986) Ion paired extraction and high performance liquid Chromatographie determination of tianeptine and its metabolites in human plasma, urine and tissues. J Chromatogr 381: 115-126
50. Olie JP, Guelfi JD, Malka R, Dulcire C, Kamoun A, Loo H (1988) Traitements de longue durée par les antidépresseurs. La tianeptine: Méthodologie d'une étude au long cours et résultats préliminaires. L'Encéphale 14: 79-84
51. Ortiz J, Mocaer E, Artigas F (1991) Effects of the antidepressant drug tianeptine on plasma and platelet serotonin in thé rat. Eur J Pharmacol 199: 335-339
52. Ortiz J, Mariscot C, Alvarez E, Artigas F (1993) Effects of the antidepressant drug tianeptine on plasma and platelet serotonin of depressive patients and healthy controls. J Affect Disord 29: 227-234
53. Osgood CD, Suci GJ, Tannenbaum PH (1975) The measurement of meaning. University Press, Urbana
54. Perris C, Monakhov K (1979) Depressive symptomatology and systematic structural analysis of the EEG. In: Gruzelier J, Flor-Henry P (eds) Hemisphere asymmetries of function and psychopathology. Elsevier, Amsterdam
55. Perris C, Monakhov K, Knorring Lvon, Botskarev V, Nikiforov A (1978) Systematic structural analysis of the electroencephalogram of depressed patients: general principles and preliminary results of an international collaborative study. Neuropsychobiology 4: 207-228
56. Poignant JC (1981) Etude pharmacologique d'un nouvel antidépresseur: la tianeptine. In: Perris C, Struwe G, Jansson B (eds) Biological psychiatry. Elsevier, Amsterdam, pp 573-578
57. Prichep LS, Lieber AL, John ER, Alper K, Gomez-Mont F, Essig-Peppard T, Flitter M (1986) Quantitative EEG in dépressive disorders. In: Shagass Ch, Josiassen RC, Roemer RA (eds) Brain electrical potentials and psychopathology. Elsevier, New York Amsterdam London, pp 223-244
58. Sacchetti G, Bonini I, Cools Waeterloos G, Samanin R (1993) Tianeptine raises dopamine and blocks stress-induced noradrenaline release in the rat frontal cortex. Eur J Pharmacol 236: 171-175
59. Saletu B (1982) Pharmaco-EEG profiles of typical and atypical antidepressants. In: Costa E, Racagni G (eds) Typical and atypical antidepressants: clinical practice. Raven Press, New York, pp 257-268
60. Saletu B (1987) The use of pharmaco-EEG in drug profiling. In: Hindmarch I, Stonier PD (eds) Human psychompharmacology. Measures and methods, vol 1. Wiley, Chichester, pp 173-200
61. Saletu B (1993) Neurophysiological and psychometric evaluation of central effects of classic and novel antidepressants. EEG mapping in depression. In: Mendlewicz J, Brunello N, Langer SZ, Racagni G (eds) New pharmacological approaches to the therapy of depressive disorders. International Academy for Biomédical and Drug Research, vol 5. Karger, Basel, pp 48-61
62. Saletu B, Grünberger J (1985) Classification and determination of cerebral bioavailability of fluoxetine: pharmacokinetic, pharmaco-EEG and psychometric analyses. J Clin Psychiatry 46:3 [Sec 2]: 45-52
63. Saletu B, Grünberger J, Flener R, Linzmayer L, Sieroslawski H (1976) Determination of psychoactivity and cerebral bioavailability of danitracene (WA 335) by quantitative pharmaco-EEG and psychometric investigations. Curr Ther Res 20: 810-820
64. Saletu B, Grünberger J, Linzmayer L, Anderer P (1980a) Classification and assessment of pharmacodynamics of SGD-SCHA 1059 (Binodaline) by quantitative EEG and psychometric analyses. In: Perris C, v Knorring L, Kemali D (eds) Clinical neurophysiological aspects of psychopathological conditions. Karger, Basel, pp 140-166 (Adv Biol Psychiat)
65. Saletu B, Grünberger J, Rajna P, Karobath M (1980b) Clovoxamine and FLUvoxamine2 biogenic amine re-uptake inhibiting antidepressants: quantitative EEG, psychometric and pharmacokinetic studies in man. J Neural Transm 49: 63-86
66. Saletu B, Grünberger J, Taeuber K, Nitsche V (1982) Relation between pharmac odynamics and -kinetics: EEG and psychometric studies with cinolazepam and nomifensine. In: Herrmann W (ed) EEG in drug research. Fischer, Stuttgart New York, pp 89-111
67. Saletu B, Gru7die;nberger J, Rajna P (1983a) Pharmaco-EEG profiles of antidepressants. Pharmacodynamic studies with fiuvoxamine. Br J Clin Pharmacol 15: 369-384
68. Saletu B, Grünberger J, Linzmayer L, Wittek R, Stöhr H (1983b) Klassifikation und Bestimmung der Pharmakodynamik eines neuen tetrazyklischen Antidepressivums, Pirlindol, mittels Pharmako-EEG und Psychometrie. Wien Klin Wochenschr 95: 481-493
69. Saletu B, Grünberger J, Linzmayer L (1985) Early clinical pharmacological studies with sercloremine-a novel antidepressant - utilizing pharmacokinetic, pharmaco-EEG and psychometric analyses. Drug Dev Res 6: 19-38
70. Saletu B, Griinberger J, Linzmayer L (1986) On central effects of serotonin re-uptake inhibitors: quantitative EEG and psychometric studies with sertraline and zimelidine. J Neural Transm 67: 241-266
71. Saletu B, Anderer P, Kinsperger K, Grünberger J (1987) Topographic brain mapping of EEG in neuropsychopharmacology, part II. Clinical applications (Pharmaco EEG imaging). Meth Find Exp Clin Pharmacol 9(6): 385-408.
72. Saletu B, Grünberger J, Anderer P, Linzmayer L, Semlitsch HV, Magni G (1992) Pharmacodynamics of venlafaxine evaluated by EEG brain mapping, psychometry and psychophysiology. Br J Clin Pharmacol 33: 589-601
73. Saletu B, Brandstätter N, Anderer P, Semlitsch HV, Binder G, Decker K, Metka M, Huber J, Knogler W (1993) Neurophysiological investigations in menopausal syndrome with and without depression and normal controls: EEG and EP mapping. Neuropsychopharmacology 9(2S): 61-61
74. Salvadori C, Ward C, Defrance R, Hopkins R (1990) The pharmacokinetics of the antidepressant tianeptine and its main metabolite in healthy humans - influence of alcohol co-administration. Fund Clin Pharmacol 4: 115-125
75. Sandler M, Coppen A, Harnett S (eds) (1991) 5-Hydroxytryptamine in psychiatry. A spectrum of ideas. Oxford Medical Publications, Oxford New York Tokyo
76. Semlitsch HV, Anderer P, Schuster P, Presslich O (1986) A solution for reliable and valid reduction of ocular artifacts applied to the P300 ERP. Psychophysiology 23: 695-703
77. Staner L, Bertolino A, Cassano GB, De Wilde J, Ferreira L, Kasas A, Mendjewicz J, Mertens C, Paes de Sousa M, Sarteschi P, Van HA, Ozun M, Loo H (1994) European multicenter study of tianeptine versus imipramine and placebo in the treatment of major depression and depressed bipolar disorders. Eur Psychiatry 9 [SuppI 1]: 140
78. Thiebot MH, Martin P, Puech AJ (1991) Animal behavioural studies in the evaluation of antidepressant drugs. Br J Psychiatry 160(15): 44-50
79. Tucker DM (1981) Asymmetrical frontal lobe function during a transient depressive state. In: Perris C, Kemali D, Vacca L (eds) Electroneurophysiology and psychopathology. Karger, Basel, pp 68-71
80. Von Zerssen D, Koeller DM, Rey ER (1970) Die Befindlichkeitsskala (B-S) - ein einfaches Instrument zur Objektivierung von Befindlichkeitsstörungen, insbesondere im Rahmen von Längsschnittuntersuchungen. Arzneimittelforschungl Drug Res 20: 915-918
81. Whitton PS, Sarna GS, Curzon G (1991) Effects of tianeptine on stress-induced behavioural deficits and 5-HT dependent behaviour. Psychopharmacology 104:81-85
82. Yozawitz A, Bruder G, Sutton S, Sharpe L, Gurland B, Fleiss J, Costa L (1979) Dichotic perception: evidence for right hemisphere dysfunction in affective psychosis. Br J Psychiatry 135: 229-237